House of Commons photo

Crucial Fact

  • His favourite word was quebec.

Last in Parliament November 2009, as Bloc MP for Montmagny—L'Islet—Kamouraska—Rivière-du-Loup (Québec)

Won his last election, in 2008, with 46% of the vote.

Statements in the House

Infrastructure February 6th, 2004

Mr. Speaker, on September 12, 2002, during his leadership campaign, the Prime Minister came to Rivière-du-Loup promising to completely upgrade Canada's deadliest highway, highway 185, but in vain. Jean Chrétien's government did not deliver the goods. Today, we need a solid commitment.

Since the safety of those who use this highway, which has taken more than 100 victims over the past 10 years, deserves non-partisan treatment, will the Minister of State for Infrastructure assure us that the Prime Minister will keep his promise before election time?

Points of Order February 6th, 2004

Mr. Speaker, the problem is that we know now that this motion contains a list of names. In order to know whether I am going to consent to the motion, I need to know if my name is on the list or not. Therefore, it is important to have the complete list to know which of us are involved in this matter.

Oil Industry February 5th, 2004

Mr. Speaker, the refineries contribute to the rising price of gasoline by decreasing their production, creating an artificial shortage. One trucking association, l'Association du camionnage du Québec, had this to say:

that someone will have to absorb these additional costs, and it may well be our customers, while the oil industry gets off lightly.

Truck drivers are carrying the whole load and the consumer may once again be held hostage by the oil industry.

What will it take for the Minister of Industry to create a petroleum monitoring agency, as recommended in the report of the Standing Committee on Industry? That is the watchdog we need.

Resumption of Debate on Address in Reply February 5th, 2004

Mr. Speaker, I listened with interest to my hon. colleague's remarks, in which he raised the issue of municipalities. In my opinion, however, the most important thing in the throne speech is what is missing.

As we look at the whole world today, an unusual phenomenon can be seen: China is about to become the world's factory. Canada has also opened its textile import markets to southern countries. It has even gone ahead of international agreements on this matter.

But there is not one word in the throne speech concerning what the Government of Canada is going to do to face these realities. Is this not a major oversight by the federal government, which is not capable of attacking the problem, finding a solution and proposing tangible action? In fact, our entire manufacturing sector is disappearing because of this new reality.

The Patent Act November 7th, 2003

Mr. Speaker, I thank you for giving me the floor back after that rather archaic interlude. We are led to the other place for the royal assent. It is always surprising for those who are elected by the public to take a second seat to those who are not.

I will conclude briefly. I will not use all my time. I think it important this afternoon that we complete if at all possible consideration of this bill at second reading.

This bill will make it possible to make drugs available to the countries most in need of them. The legislation we must analyze is complex. I wish that we could go to committee as soon as possible and that, based on that work, we could pass the bill and implement the relevant mechanisms. This would allow people in countries with the greatest development and financial difficulties to have access to quality drugs.

I think that, in this year of the war in Iraq, it would be very nice to conclude with something tangible like this. Let us hope that we can pass the bill as soon as possible, after studying it, so that we will have legislation that is workable, that will not be challenged in the courts and that will allow people to have access to these drugs.

Patent Act November 7th, 2003

Madam Speaker, I am very pleased to rise today to speak to this bill. Quite often the title of a bill does not reflect its content. Let us have a look at the title of this bill; it is an act to Amend the Patent Act and the Food and Drugs Act.

In fact, it is one of the greatest gestures towards struggling developing countries, who have been crying out for help for several years, highlighting the need for a spirit of cooperation that goes beyond the traditional approach to international trade.

We want to make sure that people in the poorest countries of the world have access to quality drugs. In this regard, the bill is very important in my opinion.

Before getting to the substance of the bill, I would like to call on every party in this House to approach this issue with as little partisanship as possible. Obviously, throughout Quebec and Canada there is a common feeling that this bill must go ahead. Indeed we have to make sure that it is the best possible bill and that it includes all the elements necessary to ensure its proper implementation.

Yes, it must be passed as soon as possible, but at the same time we must ensure that its content is appropriate and that, as political parties in this House, we stick to a non partisan approach. I believe this is very important.

I would to start by reminding the House that in the ministerial statement made in Doha in November 2001, members of the World Trade Organization recognized the seriousness of the problems experienced by developing countries in the field of public health, especially problems related to acquired immune deficiency syndrome, HIV/AIDS, tuberculosis, malaria and other diseases.

On August 30, 2003, members of the WTO agreed to amend certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights, which deals with trade, and which seemed to be preventing poor countries from importing affordable drugs.

The way the international market was organized did not allow these countries to have access to such drugs. Human tragedies are currently taking place in several countries; people keep dying from these diseases. It is not that we did not have the required drugs to treat the diseases, but it was not possible to get these drugs because of the existing provision.

With regard to the Government of Canada, the Canadian Parliament, the purpose of the bill is to ensure that our legislation can be adapted accordingly. This agreement says that the decision must be implemented in good faith for the purpose of solving public health problems, and not for industrial or commercial ends. It also says that it is important to ensure that these drugs reach their intended destination.

I believe the objectives are relevant. Changes are being proposed to the Patent Act and the Food and Drugs Act. These amendments will certainly not improve the health of those in developing countries overnight, but when they are approved by Parliament, we will be able to create an environment to improve the situation and to correct several problems that are now unacceptable.

Therefore, this is a step in the right direction. This measure complements the work done in other sectors and in other countries. We hope that all developed countries will adopt a similar approach in order to maximize the impact as soon as possible, so that satisfactory results can be attained and the spread of several of these diseases stopped.

To reach that goal, we must work in close cooperation with the WTO, the World Health Organization, and the World Intellectual Property Organization. We often hear people say that the World Trade Organization has a very insensitive approach, that it does not care about social issues. This international agreement, which is at the heart of the bill before us, will change that attitude. The WTO has agreed to talk about an issue with an important social impact. It has agreed to change the existing trade rules which were accepted and enforced by the entire industry, to the benefit of industrial promoters.

The stakeholders have agreed to include an obligation to consider the human aspect. I think this fact is worth mentioning; it sets an example that should be followed so that, in the long term, maybe the WTO and the WHO and all the international organizations will cooperate more readily and better results will be obtained.

This bill amends the Patent Act and the Food and Drugs Act. The whole issue of development, marketing and management of drug products in Quebec, in Canada and in all other countries of the world, is a very complex one. It requires a great deal of planning. We must make sure that the industry can develop new drugs, and has the financial means to do so, but also that it has the means to make those drugs available to the public as quickly as possible

On the other hand, we must ensure that there is no abuse and that we will continue to have a good system in Quebec and across Canada. We want to facilitate access to these drugs at the international level. I think that passing such legislation will be to our credit as a Parliament. I think that we will be doing something worthwhile. At the same time, we must ensure that we are not just acting on a sudden burst of generosity, as has happened in the past, without putting the right provisions in the legislation to achieve good results.

Some of these issues need to be raised. This is why I think that we should be able to study this in committee as soon as possible to ensure speedy passage of the bill. This would allow us to discuss issues such as the right of first refusal granted to industries that have developed products. We must ensure that this mechanism does not interfere in the domestic market and that such practice is consistent at the international level and takes the whole picture into account.

We must also ensure that the various partners, that is research and development companies as well as the generic sector, can adjust to meet the objectives of the bill and do what is expected of them.

We must also take into account the comments made by international development organizations, including Oxfam, which issued a release saying that it was happy about the patent amendment, but pointing out some weaknesses in this amendment. Oxfam wants to have an opportunity to make representations so that maybe we can improve that part of the bill.

It says for example that the proposed mechanisms for suspending patents can represent major progress in the fight against diseases since the high cost of patented drugs is the main cause of death for 14 million people each year. They die of diseases that could be treated. Now we want to make these drugs available. Therefore, there is a solution to this problem.

As I mentioned earlier, the amendment proposed by the government would implement a WTO agreement. Oxfam points out that the agreement covers all countries and all diseases. It is not limited to public health emergencies. This is interesting.

However, the bill provides a list of eligible pharmaceutical products that Oxfam finds unnecessarily restrictive. So, there are issues that deserve to be considered in committee. We have to listen to the research and development companies, the generic manufacturers and the international development agencies who work in the countries covered by the agreement in order to ensure that the appropriate amendments are made to this bill if need be.

We are, of course, pleased with the principle of this bill and we think that the bill needs to be further examined and then passed as soon as possible.

Given the circumstances, with a new prime minister about to take office, we understand all the tension surrounding such a bill. Everyone wants it passed, but we also need time to consider it further. The answer lies with the government. It has not yet asked to adjourn. Normally, we would get back to work in a week and, in the meantime, we can attend any committee hearings that are held.

However, if the government decides to prorogue, then it will have to live with its decision.

We have to be open to all kinds of options to ensure that such a bill is dealt with. It would be a shame to wait three, four or five months to pass this bill, knowing how great the needs are and that time is of the essence. We have before us some rather complex pieces of legislation.

A message was delivered by the Usher of the Black Rod as follows:

Mr. Speaker, Her Excellency the Governor General desires the immediate attendance of this honourable House in the chamber of the honourable the Senate.

Accordingly, the Speaker with the House went up to the Senate chamber.

And being returned:

BioChem Pharma November 7th, 2003

Mr. Speaker, the meeting yesterday with Industry Canada was crucial for the unemployed researchers from BioChem Pharma.

As proof, Shire's head of finance came from London in preparation for negotiations with Ottawa.

Can the Minister of Industry tell us if he ensured that the revitalization of BioChem Pharma would be part of the agreement with Shire to compensate for the closing of this laboratory and save several dozen jobs in research?

BioChem Pharma November 6th, 2003

Mr. Speaker, the Minister of Industry must realize that Quebec stands to lose a great deal of expertise and that time is of the essence in such matters.

We agree that Shire must honour its commitments, but can the Minister of Industry guarantee that he intends to act with due diligence to prevent Quebec from losing these researchers, who are its pride and joy?

BioChem Pharma November 6th, 2003

Mr. Speaker, on the issue of BioChem Pharma, the Minister of Industry has all the tools he needs to negotiate with Shire and revitalize this distinguished research laboratory.

With every passing day, the project's survival is threatened. Does the Minister of Industry intend to take advantage of today's meeting with Shire to ensure that BioChem Pharma's revitalization project can start up quickly?

Criminal Code November 5th, 2003

Mr. Speaker, I am saying to my colleague that we agree that a permanent solution is needed. However, again this week, the U.S. made a proposal that was turned down flat by the Canadian softwood lumber industry. It is clear that we have another year of this ahead of us. It is also clear that we must seek out new markets. At present, industries such as the small sawmills are barely staying afloat.They will not be able to survive the next year.

Is there going to be a second phase of the assistance plan for the softwood lumber industry? The Minister of Natural Resources had promised one; so did the Minister of International Trade. What is the government waiting for to implement this second phase, extend the economic diversification program, help companies by providing loan guarantees and help workers who are going to see their period of unemployment extend into the winter without any income?